美通社

2024-10-15 09:00

CooperVision to Host 4th Asia-Pacific Myopia Management Symposium in Seoul, South Korea

Held in partnership with the Korean Association of Paediatric Ophthalmology and Strabismus (KAPOS), the event will focus on advancing paediatric myopia management and shaping the future of eye health across the region.

SINGAPORE, Oct. 15, 2024 /PRNewswire/ -- CooperVision, a global leader in myopia management, is proud to announce the 4th Asia-Pacific Myopia Management Symposium (APMMS) will take place in Seoul, South Korea, on October 27, 2024. This groundbreaking event, held in collaboration with the Korean Association of Paediatric Ophthalmology and Strabismus (KAPOS), will convene distinguished eye care professionals, researchers, and industry leaders from around the world to tackle the growing prevalence of myopia in children and foster collaboration across the eye care community.

Themed "Myopia Reframed: Shaping the Future of Eye Health," APMMS 2024 will host a dynamic one-day event expecting over 300 in-person and 1,500 virtual participants. Experts from across the globe, including the Asia-Pacific region, the UK, and the USA, will discuss the latest trends in myopia control. Divided into three insightful sessions, the symposium will explore paradigm shifts in understanding myopia, present cutting-edge strategies for myopia control, and delve into future innovations and the importance of early intervention. The event will showcase research and evidence-based solutions through expert presentations and engaging panel discussions, providing insights into the latest trends and advancements in tackling myopia progression and advancing paediatric eye health.

"Myopia is a progressive and irreversible condition with significant risks if untreated, and its prevalence among young adults in Asia is alarmingly high, exceeding 80% in some regions in APAC. APMMS 2024 aims to enhance the eye care industry's understanding of myopia, its risk to ocular health and sight-threatening conditions in later life and emphasise the urgent need for early intervention" said Kathy Park, President of CooperVision Asia Pacific. "By uniting the foremost experts in the field, our goal is to elevate clinical practices and establish new standards of care that will shape the future of paediatric eye health across the region."

The symposium will highlight key findings from CooperVision's seven-year clinical study on MiSight® 1 day, the first FDA-approved soft contact lens proven to slow myopia progression in children. Additionally, it will present results from a ten-year investigator-initiated study, led by Professor Nicola Logan of Aston University, UK, confirming the safety of long-term daily disposable hydrogel soft contact lens wear, MiSight® 1 day.

Dr. Paik Hae-Jung, President of KAPOS and Korean Myopia Society, Gachon University Gil Medical Center, Korea, shared, "South Korea is confronting a pressing myopia epidemic, notably affecting our younger generations. The 4th APMMS offers a pivotal moment for us to join forces with leading eye care professionals to advance our strategies and deepen our understanding of myopia management. We're thrilled to partner with CooperVision in this effort, aligning on a shared vision to elevate and promote myopia management as a cornerstone of paediatric eye care."

The symposium will be hosted at the Grand Walkerhill Seoul in South Korea on October 27, 2024, from 9:00AM to 5:30PM Korea Standard Time, offering both in-person and virtual attendance options. CooperVision invites eye care professionals, researchers, and professional associations to join this important conversation, collaborate with peers, and share their expertise in combating the rising myopia epidemic.

Register now to secure your spot at APMMS 2024 and be part of the movement transforming paediatric eye health across Asia-Pacific.

About CooperVision

CooperVision, a division of CooperCompanies (Nasdaq:COO), is one of the world's leading manufacturers of contact lenses. The company produces a full array of daily disposable, two-week and monthly soft contact lenses that feature advanced materials and optics, and premium rigid gas permeable lenses for orthokeratology and scleral designs. CooperVision has a strong heritage of addressing the toughest vision challenges such as astigmatism, presbyopia, childhood Myopia, and highly irregular corneas; and offers the most complete portfolio of spherical, toric and multifocal products available. Through a combination of innovative products and focused practitioner support, the company brings a refreshing perspective to the marketplace, creating real advantages for customers and wearers. For more information, visit www.coopervision.com.

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on improving lives one person at a time. The Company operates through two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, improving the vision of millions of people every day. CooperSurgical is a leading fertility and women's health company dedicated to assisting women, babies and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000 with products sold in over 130 countries. For more information, please visit www.coopercos.com.

source: CooperVision

送禮活動浪接浪!想緊貼著數活動消息?即Like etnet Facebook專頁!► 立即讚好

人氣文章
最近7天
1
高息定存 | 6個月港元定存3.8厘新高,188日快閃優惠3.68厘
2
高息定存 | 富邦推快閃定存優惠3個月3.9厘,華僑188日3.68厘
3
高息定存 | 工銀亞洲推3個月5厘息搶新客,招商永隆推快閃優惠
4
【FOCUS】零售寒冬襲京滬港,逆市奇葩值借鏡
5
港股 | 蕭猷華:恒指料退守至18600點,宜逢低吸納
6
內銀股 | 人行再提擇機減息降準,內銀獲中金唱好,應該點部署?
7
神州經脈 | 換手機可獲政府補貼,政策利率將降,滬指周挫逾5%
8
大國博弈 | 【FOCUS】騰訊商湯寧德重挫,CMC清單劍指軍民融合
9
新股掛牌 | 布魯可首日掛牌升41%,每手賺7395元
10
加州山火 | 【FOCUS】洛杉磯烈火焚城,天災背後藏人禍
11
高息定存 | 一周高息合集,恒生1個月定存4厘,工銀亞洲3個月最高5厘
12
高息定存 | 渣打特選客6個月3.48厘,建行亞洲推1個月6.18厘高息吸客
13
高息定存 | 花旗3個月港元定存息加至4厘,信銀國際3.88厘
14
一本萬利 | 2025年的五個「勿」(有片)
15
英偉達 | DeepSeek衝擊AI晶片行業結構 英偉達暴跌仍未急抄底
16
互聯支付 | 黃俊碩:轉數快與IBPS互聯支付所產生的發展契機
17
高息定存 | 一周高息合集,銀行高息吸客,低門檻10萬享6.18厘,3個月最高5厘
18
港股 | 蕭猷華:恒指春節前目標21500點
19
高息定存 | 一周高息合集,銀行高息搶存,富邦1個月4.88厘,華僑1年期3.6厘
20
神州經脈 | 基金賣股票據報受限,滬指連跌四日,人行穩匯率
21
專訪|洪灝:美股更大跌幅在前面,恐需習慣4%通脹(有片)
22
易經看世界 | 從乙巳年立春八字看香港前景:哪行業當旺?哪行業運滯?(有片)
23
習近平應約與特朗普通電話,特:冀盡快與習見面
24
財政預算案2025 | 羅兵咸料本財年財赤948億,財政儲備降至紀錄新低
25
加州山火 | 美國洛杉磯大火失控,被迫撤離人數增至18萬
26
【FOCUS】去年貿易順差破紀錄,中國擴消費增緊迫感
27
高息定存 | 一周高息合集,部分銀行逆市加息,南商3個月加至3.8厘
28
賣地計劃 | 政府今季推一幅東涌住宅地涉745伙,全年供應不達標
29
加州山火造成超500億美元損失,大量房主未買保險
30
【FOCUS】侵侵就職倒數一周,美元及油價劇本臨揭盅
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

【etnet 30周年】多重慶祝活動一浪接一浪,好禮連環賞!

【蛇年行大運 新年好賞「飾」】etnet賞太歲開運趨吉避凶神器

etnet榮獲HKEX Awards 2023 「最佳證券數據供應商」大獎

大國博弈

貨幣攻略

說說心理話

聖誕新年特輯

Watch Trends 2024

北上食買玩

Art Month 2024

秋天養生食療

山今養生智慧

輕鬆護老